Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $44.9300 (2.25%) ($44.9300 - $44.9500) on Tue. Apr. 13, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.6% (three month average) | RSI | 42 | Latest Price | $44.9300(2.25%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -0.9% a day on average for past five trading days. | Weekly Trend | TGTX declines -0.8% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(67%) ARKG(63%) ARKK(58%) IBB(58%) IWO(58%) | Factors Impacting TGTX price | TGTX will decline at least -1.8% in a week (0% probabilities). VIXM(-42%) VXX(-35%) UUP(-17%) IGOV(-4%) UNG(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.8% (StdDev 3.6%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $39.01(-13.18%) | Inflection Point | Yes | Resistance Level | $46.63 | 5 Day Moving Average | $45.29(-0.79%) | 10 Day Moving Average | $46.31(-2.98%) | 20 Day Moving Average | $46.63(-3.65%) | To recent high | -17% | To recent low | 7.8% | Market Cap | $5.69b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |